MAPK1 and lung carcinoma: In lung cancer cells, lysoPC could elevate mRNA and protein expression of PI3K‐ and ERK‐signal pathways associated with 10 kinases in lysoPC‐treated cells, presenting multi‐kinase‐based molecular mechanisms (Figure S6I,J).